Direct oral anticoagulation and mortality in moderate to high-risk atrial fibrillation
Sign Up to like & getrecommendations! Published in 2019 at "Heart"
DOI: 10.1136/heartjnl-2018-314476
Abstract: Objective Although direct oral anticoagulants (DOAC) are the recommended antithrombotic therapy for patients with non-valvular atrial fibrillation (NVAF), anticoagulation in patients with NVAF is still inadequate. The effect of withholding DOAC therapy on patient survival… read more here.
Keywords: anticoagulation; risk; patients nvaf; mortality ... See more keywords
Management of Direct-Acting Oral Anticoagulants Surrounding Dental Procedures With Low-to-Moderate Risk of Bleeding
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Pharmacy Practice"
DOI: 10.1177/0897190017707126
Abstract: The purpose of this article is to review the available evidence regarding how to safely manage direct-acting oral anticoagulant (DOAC) therapy in patients requiring dental procedures with low-to-moderate risk of bleeding. A literature search was… read more here.
Keywords: risk; dental procedures; low moderate; risk bleeding ... See more keywords
Outcomes Associated With Resuming Direct Oral Anticoagulant Therapy Following Admission for a Gastrointestinal Bleed
Sign Up to like & getrecommendations! Published in 2020 at "Annals of Pharmacotherapy"
DOI: 10.1177/1060028020912429
Abstract: Background: Although direct oral anticoagulants (DOACs) carry a lower bleeding risk compared with warfarin, gastrointestinal bleeds (GIB) are a known complication. There are limited data observing outcomes associated with resuming DOACs following a GIB. Objective:… read more here.
Keywords: gib; admission; outcomes associated; direct oral ... See more keywords
Direct Oral Anticoagulants and Mortality in Atrial Fibrillation
Sign Up to like & getrecommendations! Published in 2018 at "Blood"
DOI: 10.1182/blood-2018-99-111182
Abstract: Background Direct oral anticoagulants (DOACs) are at least as effective as vitamin K antagonists (VKAs) for stroke prevention in patients with non-valvular atrial fibrillation (NVAF). DOACs are associated with less intracranial hemorrhage and are easier… read more here.
Keywords: therapy; nvaf patients; doac therapy; mortality ... See more keywords
Management of bleeding or urgent interventions in patients treated with direct oral anticoagulants: 2017 recommendations for Poland.
Sign Up to like & getrecommendations! Published in 2017 at "Polish archives of internal medicine"
DOI: 10.20452/pamw.3995
Abstract: Direct oral anticoagulants (DOACs) such as apixaban, dabigatran, edoxaban, and rivaroxaban are mainly used in the prevention of thromboembolic complications in patients with atrial fibrillation (AF) and in the treatment of venous thromboembolism. As compared with vitamin… read more here.
Keywords: bleeding urgent; oral anticoagulants; direct oral; management bleeding ... See more keywords